TERT provides instructions for telomerase, a tool cells use to protect chromosome ends (telomeres) during repeated cell division. This gene helps your body maintain tissues that need steady renewal, such as blood and the lung lining. If the TERT gene does not work well, telomeres may shorten, which can contribute to low blood counts, pulmonary fibrosis, or dyskeratosis congenita. Some TERT variants that boost telomerase are linked to higher cancer risk, but risk is not the same as a diagnosis.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or manage activities throughout the body. In some cases, genes provide the code for proteins, which do much of the day-to-day work inside cells. In other cases, genes are more involved in directing when and where certain body processes happen, and how active they are. Taken together, genes affect how your body grows and works, and they can influence how you react to food, stress, or medicines. To go deeper into this subject, you can read more in the LearnHub.
Overview
TERTGene function
What if the gene works
Many dividing cells rely on the TERT gene to help maintain telomeres, the protective ends of chromosomes. This supports normal cell renewal, especially in stem cells and some immune cells, by helping chromosomes stay stable as cells divide.
Risk
What if the gene does not work
When the TERT gene doesn’t work well, telomeres shorten faster, which can cause low counts and marrow failure and may raise the chance of lung or liver scarring. Changes range from milder to severe, affecting which problems appear and when.
Treatment
What does that mean for your treatment
Certain TERT gene variants can raise toxicity from chemotherapy, radiation, or transplant conditioning, so care may use lower intensity regimens and closer blood and lung monitoring. Androgens such as danazol may help some short telomere related marrow failure.
Conditions associated with TERT
Gene function
What if the gene works
Every time a cell divides, it has to copy and package its DNA neatly so the new cells work normally. The TERT gene helps with this by supporting the maintenance of telomeres, which are protective tips on chromosomes. Across many tissues, the TERT gene contributes to steady, routine cell activity, especially in cells that need to keep dividing over time.
The TERT gene provides the working part of telomerase (an enzyme that rebuilds telomeres, the protective tips of chromosomes). It adds repeated DNA building blocks to help keep telomeres from shortening too quickly during normal cell division.
By helping maintain telomere length, the TERT gene supports cells that need to divide many times over a lifetime. This helps tissues with regular turnover, such as blood and skin, keep producing new cells in an orderly way.
TERT activity is higher in stem cells and early reproductive cells, where long-term self-renewal is needed. It helps these cells keep a reserve for growth, healing, and normal development.
Telomeres act like protective caps that keep chromosome ends from being treated like damaged DNA. Through telomere maintenance, the TERT gene helps chromosomes stay organized during cell division. This supports reliable passing of genetic information from one cell to the next.
What is a variant?
A genetic variant is a minor difference in the DNA code within a gene. These differences are widespread and help explain normal human variation, such as changes in looks, metabolism, or the way the body reacts to environmental factors. Many variants do not lead to any noticeable changes and are part of typical genetic diversity. In certain situations, though, a variant can affect how a gene works in a more meaningful way and may play a role in, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the TERT gene can lower the body’s telomerase activity, which can lead to unusually short telomeres (the protective tips on chromosomes) and reduced ability for certain tissues to renew themselves. Depending on the variant, TERT gene mutation symptoms may include earlier graying, low blood counts from bone marrow failure, lung scarring (pulmonary fibrosis), or liver problems, while other changes cause milder or later-onset effects. DNA changes range from milder variants to severe mutations, which can influence how early features appear and how many body systems are involved.
How variants are linked to conditions
Changes in the TERT gene are most strongly linked to inherited telomere disorders that can cause bone marrow failure (including aplastic anemia), low blood counts, and scarring in the lungs, with a well-known pattern sometimes described as a TERT gene mutation and pulmonary fibrosis. Depending on the variant, a diagnosis may also include dyskeratosis congenita and related conditions affecting the liver or immune system. More common TERT variants found in population studies are associated with a higher risk of several cancers, including melanoma, glioma, and lung cancer, but these risk links do not guarantee that cancer will develop.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology, and they occur widely across the general population. In most cases, these variants do not directly change health and instead represent normal differences among people. For many genes, having a variant that has been linked to a condition points to a potential association rather than a certain diagnosis, particularly when risk is shaped by multiple genes and environmental influences. In certain situations, though, one well-studied variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
With a harmful change in the TERT gene, risk is often strongly driven by the variant itself, and there is not enough evidence to say that diet, vitamins, or exercise can lower the chance of related conditions. Some exposures can still make problems more likely or worse, especially smoking and long-term contact with lung irritants like dust or fumes. Avoiding unnecessary radiation or certain harsh medicines may also help reduce complications for some people with TERT.
Inheritance of TERT variants
Changes in the TERT gene most often run in families in an autosomal dominant pattern, so a parent of any sex can pass the same change to a child of any sex, with a 1 in 2 (50%) chance in each pregnancy. Less commonly, inheritance of the TERT gene variants is autosomal recessive, meaning a child typically needs one changed copy from each parent.
What does my TERT result mean for my family?
Seek medical advice if a result involving the TERT gene comes up in your family, especially if several relatives have had certain cancers or serious lung or bone-marrow problems (low blood counts). A genetics or cancer specialist can explain what it may mean for close relatives and which family members might need closer checkups. Get support sooner if the result is causing high stress or affecting treatment choices.
Genetic information
Genetic testing
How you find out about variants
You can find out whether you carry a change in the TERT gene through TERT genetic testing, usually done on a blood sample or saliva swab. A certified lab reads the gene’s DNA letters, compares them with a reference sequence, and reports any variants, often classifying them as pathogenic, benign, or of uncertain significance.
When should I consider getting a genetic test?
Consider genetic testing for the TERT gene when you or close relatives have unexplained lung scarring (pulmonary fibrosis), long‑lasting low blood counts, or bone marrow failure. It can also be helpful when several family members have these issues, especially with early graying of hair or unusual liver disease. Testing may clarify whether a shared inherited change is contributing and can guide family planning and medical follow‑up.
A genetic result is only one part of your health story
A genetic test result can be helpful, but what it can tell you varies based on the health condition and the specific kind of variant found. Over time, how your body functions is shaped by many factors, including lifestyle, environment, age, and your medical history. For some conditions, particularly those affected by many genes, genetic information offers context rather than a definite prediction and makes the most sense when considered alongside other parts of care. In other situations, a genetic finding may give a straightforward explanation. For topics like how someone responds to medications, genetic results can help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines, and most of these differences come from genes involved in drug processing or drug targets rather than from the TERT gene. The same dose can lead to different drug levels in the body because some people break down or clear medications faster or slower based on their inherited DNA. These common differences can influence how well a treatment works or how likely you are to notice side effects. In clinical care, medication response is usually interpreted using your symptoms, lab results, other health conditions, and any available pharmacogenetic findings.
What is Pharmacogenetics?
Pharmacogenetics focuses on how inherited genetic differences can affect the way you respond to medications. It examines relationships between specific genes and specific drugs to explain why the same treatment may have different effects in different people. With many medicines, your genes can influence how powerfully a drug works or how your body breaks it down. Understanding these connections can support more informed, more personalized treatment decisions. More information on this topic is available in the LearnHub.
Drugs influenced by the TERT gene
When should I seek medical advice?
Seek medical advice if you or close relatives have unexplained low blood counts, lung scarring with shortness of breath, or ongoing liver problems, which can be seen in some TERT-related conditions. Also discuss TERT concerns before chemotherapy, radiation, or a stem cell transplant, and get urgent care for sudden severe breathlessness or bleeding.
History
In recent decades, awareness of this gene’s role has grown as telomere research moved into everyday medical genetics. Telomerase activity was first identified in the late 1980s, and telomeres became a major focus for understanding why cells age and why some cancers keep dividing. In 1997, researchers reported the human telomerase catalytic component, now known as the TERT gene, a key step that allowed more precise testing and disease research. Work on telomeres and telomerase was recognized with the 2009 Nobel Prize in Physiology or Medicine, which helped bring the field into the mainstream. Since then, studies of TERT changes have been central to understanding several inherited telomere related conditions and some cancer risks.